Zacks: Brokerages Expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Post Quarterly Sales of $204.90 Million

Analysts expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) to announce sales of $204.90 million for the current quarter, according to Zacks. Five analysts have made estimates for Tandem Diabetes Care’s earnings, with the highest sales estimate coming in at $206.50 million and the lowest estimate coming in at $203.82 million. Tandem Diabetes Care […]

Related Keywords

United States ,Kimd Blickenstaff ,Davidb Berger ,Piper Sandler ,Tandem Diabetes Care Inc ,Zacks Investment Research ,Nasdaq ,Wells Fargo Company ,Ci Investments Inc ,Moors Cabot Inc ,Byrne Asset Management ,Sandy Cove Advisors ,Citigroup ,Tandem Diabetes Care ,Get Rating ,Diabetes Care ,Tandem Diabetes ,Wells Fargo ,Investment Research ,Director Kim ,Asset Management ,Nasdaq Tndm ,Tndm ,Medical ,Ratings ,Consensus ,